Sequenom granted GATC European rights to patents covering the development of prenatal aneuploidy tests using fetal DNA in maternal plasma

Sequenom Inc.

U.S. / Tools, Services, and Manufacturing

$550.9m on 08/12/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

GATC Biotech AG

Germany / Tools, Services, and Manufacturing

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced